Browsing Tag: Cyclarity

UDP-003, a cyclodextrin-based drug, safely reduces 7-ketocholesterol in Phase 1, potentially reversing atherosclerosis instead of just slowing it. A novel drug that removes toxic cholesterol byproduct...